Giménez-Arnau E, Missailidis S, Stevens M F
Cancer Research Laboratories, School of Pharmaceutical Sciences, University of Nottingham, UK.
Anticancer Drug Des. 1998 Jul;13(5):431-51.
The non-covalent interactions between a series of new tetracyclic acridine derivatives (5-11) and DNA have been studied by spectrophotometric analysis, fluorescences quenching, thermal denaturation, and circular and linear dichroism. In order to compare the extent of the DNA binding by compounds 5-11 in their neutral and cationic forms, all experiments were conducted at pH 7.4 (physiological pH) and 5.0. The results indicated that compounds 5-11 are strong DNA-binding ligands with DNA affinities comparable to that of m-AMSA (1) or even higher. They showed a stronger DNA binding activity at pH 5.0 as a result of the N-protonation of the pyridoacridine aromatic chromophore. Ethidium-DNA fluorescence assays showed an A-T base pair preference of the binding distinguishing these novel compounds from simple acridines which show a slight G-C base pair preference. Circular and linear dichroism studies indicated that the drugs bind to DNA by undergoing intercalation inside the duplex macromolecule at high DNA:drug ratios and revealed alternative binding modes at low DNA:drug ratios.
通过分光光度分析、荧光猝灭、热变性以及圆二色性和线性二色性研究了一系列新型四环吖啶衍生物(5 - 11)与DNA之间的非共价相互作用。为了比较化合物5 - 11在中性和阳离子形式下与DNA结合的程度,所有实验均在pH 7.4(生理pH)和5.0条件下进行。结果表明,化合物5 - 11是强DNA结合配体,其与DNA的亲和力与间位氨基吖啶(1)相当,甚至更高。由于吡啶吖啶芳香发色团的N - 质子化,它们在pH 5.0时表现出更强的DNA结合活性。溴化乙锭 - DNA荧光分析表明,这些新型化合物的结合具有A - T碱基对偏好,这使其区别于表现出轻微G - C碱基对偏好的简单吖啶。圆二色性和线性二色性研究表明,在高DNA:药物比例下,药物通过插入双链大分子内部与DNA结合,而在低DNA:药物比例下则显示出其他结合模式。